Effect of an Oral Supplement on the Total Energy and Protein Intake of Head and Neck Cancer Patients in the Last 2 Weeks of Radiation Therapy

Efficacy of an Oral Nutrition Supplement on the Total Caloric and Protein Intake of Head and Neck Cancer Patients During the Last 2 Weeks of Radiation Therapy

Status

Withdrawn

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00375700

Enrollment

Registered

2006-09-13

Start date

2006-11-30

Completion date

2010-01-31

Last updated

2016-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer

Keywords

food, diet, oral supplement, head and neck cancer, radiation

Brief summary

In this study, an oral nutrition supplement has been developed that take into consideration: the nutritional requirements, treatment side-effects and taste preferences of head and neck cancer patients; the acceptance of a supplement when experiencing radiation therapy side-effects; and the taste preferences of head and neck cancer patients which may affect the supplement intake. We hope to increase dietary intake during the last 2 weeks of radiation therapy.

Interventions

DIETARY_SUPPLEMENTNutritional Supplement

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years or older * diagnosed with head and neck cancer including the lip, oral cavity, salivary glands, paranasal sinuses, oropharynx, nasopharynx, hypopharynx, larynx and thyroid. * all histologic types of cancer * all tumour stages according to American Joint Committee for Cancer (AJCC) Staging * all forms of RT including standard or investigational for head and neck cancers * alert and mentally competent * English speaking

Exclusion criteria

* an allergy or intolerance to any of the substances used in the nutrition supplement * Type I or II diabetes mellitus * renal insufficiency * unable to swallow * additional criteria of all forms of chemotherapy standard or investigational or combination of radiation/chemotherapy standard or investigational for head and neck cancers

Design outcomes

Primary

Measure	Time frame
total energy and protein intake	Study completion

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026